333 related articles for article (PubMed ID: 28658592)
41. Dectin-1 is not required for controlling Candida albicans colonization of the gastrointestinal tract.
Vautier S; Drummond RA; Redelinghuys P; Murray GI; MacCallum DM; Brown GD
Infect Immun; 2012 Dec; 80(12):4216-22. PubMed ID: 22988015
[TBL] [Abstract][Full Text] [Related]
42. Pathways regulating cytosolic phospholipase A2 activation and eicosanoid production in macrophages by Candida albicans.
Suram S; Gangelhoff TA; Taylor PR; Rosas M; Brown GD; Bonventre JV; Akira S; Uematsu S; Williams DL; Murphy RC; Leslie CC
J Biol Chem; 2010 Oct; 285(40):30676-85. PubMed ID: 20643646
[TBL] [Abstract][Full Text] [Related]
43. The Drosophila Toll pathway controls but does not clear Candida glabrata infections.
Quintin J; Asmar J; Matskevich AA; Lafarge MC; Ferrandon D
J Immunol; 2013 Mar; 190(6):2818-27. PubMed ID: 23401590
[TBL] [Abstract][Full Text] [Related]
44. Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1.
Marakalala MJ; Vautier S; Potrykus J; Walker LA; Shepardson KM; Hopke A; Mora-Montes HM; Kerrigan A; Netea MG; Murray GI; Maccallum DM; Wheeler R; Munro CA; Gow NA; Cramer RA; Brown AJ; Brown GD
PLoS Pathog; 2013; 9(4):e1003315. PubMed ID: 23637604
[TBL] [Abstract][Full Text] [Related]
45. Normal host defense during systemic candidiasis in mannose receptor-deficient mice.
Lee SJ; Zheng NY; Clavijo M; Nussenzweig MC
Infect Immun; 2003 Jan; 71(1):437-45. PubMed ID: 12496194
[TBL] [Abstract][Full Text] [Related]
46. Targeting CBLB as a potential therapeutic approach for disseminated candidiasis.
Xiao Y; Tang J; Guo H; Zhao Y; Tang R; Ouyang S; Zeng Q; Rappleye CA; Rajaram MV; Schlesinger LS; Tao L; Brown GD; Langdon WY; Li BT; Zhang J
Nat Med; 2016 Aug; 22(8):906-14. PubMed ID: 27428899
[TBL] [Abstract][Full Text] [Related]
47. E3 ubiquitin ligase Cbl-b negatively regulates C-type lectin receptor-mediated antifungal innate immunity.
Zhu LL; Luo TM; Xu X; Guo YH; Zhao XQ; Wang TT; Tang B; Jiang YY; Xu JF; Lin X; Jia XM
J Exp Med; 2016 Jul; 213(8):1555-70. PubMed ID: 27432944
[TBL] [Abstract][Full Text] [Related]
48. CD4(+) T-cell survival in the GI tract requires dectin-1 during fungal infection.
Drummond RA; Dambuza IM; Vautier S; Taylor JA; Reid DM; Bain CC; Underhill DM; Masopust D; Kaplan DH; Brown GD
Mucosal Immunol; 2016 Mar; 9(2):492-502. PubMed ID: 26349660
[TBL] [Abstract][Full Text] [Related]
49. Complement receptor 3-dependent engagement by
Kunanopparat A; Dinh TTH; Ponpakdee P; Padungros P; Kaewduangduen W; Ariya-Anandech K; Tummamunkong P; Samaeng A; Sae-Ear P; Leelahavanichkul A; Hirankarn N; Ritprajak P
Open Biol; 2024 May; 14(5):230315. PubMed ID: 38806144
[No Abstract] [Full Text] [Related]
50. Candida albicans triggers NADPH oxidase-independent neutrophil extracellular traps through dectin-2.
Wu SY; Weng CL; Jheng MJ; Kan HW; Hsieh ST; Liu FT; Wu-Hsieh BA
PLoS Pathog; 2019 Nov; 15(11):e1008096. PubMed ID: 31693704
[TBL] [Abstract][Full Text] [Related]
51. Dectin-1 embraces Candida glabrata.
Del Fresno Sánchez C
Virulence; 2017 Nov; 8(8):1478-1480. PubMed ID: 28727942
[No Abstract] [Full Text] [Related]
52. Effects of immune suppression in murine models of disseminated Candida glabrata and Candida tropicalis infection and utility of a synthetic peptide vaccine.
Xin H
Med Mycol; 2019 Aug; 57(6):745-756. PubMed ID: 30521033
[TBL] [Abstract][Full Text] [Related]
53. Two unlike cousins: Candida albicans and C. glabrata infection strategies.
Brunke S; Hube B
Cell Microbiol; 2013 May; 15(5):701-8. PubMed ID: 23253282
[TBL] [Abstract][Full Text] [Related]
54. Dectin-1 is required for miR155 upregulation in murine macrophages in response to Candida albicans.
Agustinho DP; de Oliveira MA; Tavares AH; Derengowski L; Stolz V; Guilhelmelli F; Mortari MR; Kuchler K; Silva-Pereira I
Virulence; 2017 Jan; 8(1):41-52. PubMed ID: 27294852
[TBL] [Abstract][Full Text] [Related]
55. Transcriptional and functional insights into the host immune response against the emerging fungal pathogen Candida auris.
Bruno M; Kersten S; Bain JM; Jaeger M; Rosati D; Kruppa MD; Lowman DW; Rice PJ; Graves B; Ma Z; Jiao YN; Chowdhary A; Renieris G; van de Veerdonk FL; Kullberg BJ; Giamarellos-Bourboulis EJ; Hoischen A; Gow NAR; Brown AJP; Meis JF; Williams DL; Netea MG
Nat Microbiol; 2020 Dec; 5(12):1516-1531. PubMed ID: 32839538
[TBL] [Abstract][Full Text] [Related]
56. Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms.
Cataldi V; Di Campli E; Fazii P; Traini T; Cellini L; Di Giulio M
Med Mycol; 2017 Aug; 55(6):624-634. PubMed ID: 27915303
[TBL] [Abstract][Full Text] [Related]
57. Candida glabrata: a deadly companion?
Bolotin-Fukuhara M; Fairhead C
Yeast; 2014 Aug; 31(8):279-88. PubMed ID: 24861573
[TBL] [Abstract][Full Text] [Related]
58. The Interaction of
Kottom TJ; Hebrink DM; Jenson PE; Nandakumar V; Wüthrich M; Wang H; Klein B; Yamasaki S; Lepenies B; Limper AH
J Immunol; 2017 May; 198(9):3515-3525. PubMed ID: 28298521
[No Abstract] [Full Text] [Related]
59. One small step for a yeast--microevolution within macrophages renders Candida glabrata hypervirulent due to a single point mutation.
Brunke S; Seider K; Fischer D; Jacobsen ID; Kasper L; Jablonowski N; Wartenberg A; Bader O; Enache-Angoulvant A; Schaller M; d'Enfert C; Hube B
PLoS Pathog; 2014 Oct; 10(10):e1004478. PubMed ID: 25356907
[TBL] [Abstract][Full Text] [Related]
60. Aspartyl proteases in
Rasheed M; Battu A; Kaur R
J Biol Chem; 2018 Apr; 293(17):6410-6433. PubMed ID: 29491142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
